Because decreased Nefl expression and its excessive phosphorylation (at Ser473 in mouse Nefl, which corresponds to Ser472 in human NEFL; Hill et al, 1991; Basso et al, 2004) are biomarkers of axonal damage in PD patients, we analyzed these molecular alterations. The gene discussed is NEFL; the disease is Parkinson disease.